---
layout: post
title: "NASDAQ: MREO INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors of an April 6, 2026 Deadline"
date: 2026-02-18T14:49:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/nasdaq-mreo-investor-alert-berger-montague-advises-mereo-biopharma-group-plc-nasdaq-mreo-investors-of-an-april-6-2026-deadline-302689215.html
significance: 8.00
---

<p>PHILADELPHIA, Feb. 18, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Mereo BioPharma Group plc (NASDAQ: MREO) ("Mereo" or the "Company") on behalf of investors who purchased American Depositary Shares...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/nasdaq-mreo-investor-alert-berger-montague-advises-mereo-biopharma-group-plc-nasdaq-mreo-investors-of-an-april-6-2026-deadline-302689215.html)

**Published:** 2026-02-18 14:49:00 +0000

**Significance Score:** 8.00

[View original](https://www.prnewswire.com/news-releases/nasdaq-mreo-investor-alert-berger-montague-advises-mereo-biopharma-group-plc-nasdaq-mreo-investors-of-an-april-6-2026-deadline-302689215.html)
